Niti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of Business

AiMeD lauds PM Modi for Landmark Reforms under Jan Vishwas Bill

New Delhi: The Jan Vishwas (Amendment) bill passed ‘for ‘ease of businesses’ has pleased domestic medical device industry greatly. AiMeD, the body representing them, has profusely thanked PM Modi for enabling bill. It has also thanked Niti Aayog nd &DPIIT for making this happen.  Rajiv Nath, AiMeD leader has termed it a landmark bill.

The Association of Indian Medical Devices Industry (AiMeD) has extended its heartfelt appreciation to Rajiv Gauba Committee under Niti Aayog  and the Department for Promotion of Industry and Internal Trade (DPIIT) for their exemplary coordination with the Ministry of Health & Family Welfare (MoH&FW), Central Drugs Standard Control Organisation (CDSCO), and other stakeholders in driving the passage of the Jan Vishwas (Amendment of Provisions) Bill, 2026.

This landmark legislation, passed by both Houses of Parliament on April 3, 2026, represents a transformative step under the Prime Minister’s initiative for regulatory reforms. By decriminalizing numerous punitive measures previously applied to medical devices under the Drugs & Cosmetics Act, 1940—replacing imprisonment for minor procedural violations with graded monetary penalties and structured adjudication—the Bill shifts towards a governance-focused framework with minimal government interference. These changes, including amendments to Sections 27A(ii) and 28A, alleviate the compliance burden, reduce litigation, and foster a trust-based ecosystem that empowers the medical devices industry to innovate and grow while upholding public health safeguards.

AiMeD commends this whole-of-government approach, involving 23 Ministries, for rationalizing over 1,000 offences across 79 Central Acts and promoting Ease of Doing Business in the health sector.

Rajiv Nath, Forum Coordinator of AiMeD, stated: “We applaud Niti Aayog and DPIIT’s pivotal role in coordinating with MoH&FW and CDSCO to decriminalise many punitive measures that were earlier applicable under Drugs & Cosmetics Act on Medical Devices under the Prime Minister’s initiative to bring in regulatory reforms designed on more of governance and less of government interference.”

These reforms will streamline operations for Indian medical devices manufacturers, enhance global competitiveness, and align with international best practices, ultimately benefiting patients and healthcare delivery across the country.